CRISPR Therapeutics AG SEC filings CRSP
CRISPR Therapeutics AG has 880 filings in SEC EDGAR's recent list, going back to May 13, 2016. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jun 5, 2026 | — |
| 424B5 | Prospectus supplement | Oct 15, 2025 | — |
| 424B5 | Prospectus supplement | May 19, 2025 | — |
| S-3ASR | Automatic shelf registration | Aug 5, 2024 | — |
| S-8 | Employee stock plan registration | Aug 5, 2024 | — |
| 424B5 | Prospectus supplement | Feb 13, 2024 | — |
| S-8 | Employee stock plan registration | Aug 7, 2023 | — |
| S-8 | Employee stock plan registration | Aug 8, 2022 | — |
| S-3ASR | Automatic shelf registration | Jul 29, 2021 | — |
| 424B5 | Prospectus supplement | Jan 15, 2021 | — |
| 424B5 | Prospectus supplement | Dec 11, 2020 | — |
| S-8 | Employee stock plan registration | Jul 27, 2020 | — |
| 424B5 | Prospectus supplement | Jul 1, 2020 | — |
| 424B5 | Prospectus supplement | Jun 29, 2020 | — |
| 424B5 | Prospectus supplement | Nov 21, 2019 | — |
| 424B5 | Prospectus supplement | Nov 19, 2019 | — |
| 424B5 | Prospectus supplement | Aug 30, 2019 | — |
| S-8 | Employee stock plan registration | Jul 29, 2019 | — |
| 424B5 | Prospectus supplement | Nov 9, 2018 | — |
| 424B5 | Prospectus supplement | Sep 24, 2018 | — |
| 424B5 | Prospectus supplement | Sep 21, 2018 | — |
| 424B5 | Prospectus supplement | Sep 19, 2018 | — |
| S-3ASR | Automatic shelf registration | Sep 19, 2018 | — |
| 424B5 | Prospectus supplement | Aug 31, 2018 | — |
| S-8 | Employee stock plan registration | Jun 1, 2018 | — |
| 424B5 | Prospectus supplement | Jan 5, 2018 | — |
| 424B5 | Prospectus supplement | Jan 3, 2018 | — |
| S-3/A | Filing | Dec 1, 2017 | — |
| S-3 | Shelf registration | Nov 9, 2017 | — |
| S-8 | Employee stock plan registration | Nov 8, 2017 | — |
| S-8 | Employee stock plan registration | Oct 20, 2016 | — |
| 424B4 | Prospectus | Oct 19, 2016 | — |
| S-1/A | Amended registration statement | Oct 14, 2016 | — |
| S-1/A | Amended registration statement | Oct 7, 2016 | — |
| S-1 | Registration statement | Sep 9, 2016 | — |
Showing 35 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CRSP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Switzerland
- Headquarters
- Zug
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1674416
- Former names
- CRISPR Therapeutics AG (until Nov 2, 2026)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.